Search
-
Public remain pessimistic on Britain’s economy
Public remain pessimistic on Britain’s economy.
Little change in leadership satisfaction ratings for May and Corbyn.
-
Ipsos Research Highlights - February 2018
Ipsos's Research Highlights for February 2018 includes Scotland Perils of Perception, a rise in public concern for the NHS and the most popular Royals.
-
No! Jeremy Corbyn
Independent analyst David Cowling looks at the position of the Labour Party in the latest opinion polls.
-
Prince William and Prince Harry are the nation’s most liked Royals
The Ipsos Political Monitor for January 2018 reveals the latest public opinion of the Royal Family and its members.
-
Ipsos Issues Index: 2017 in review
The NHS and Brexit replace Immigration as the biggest issues facing Britain in 2017
-
What worries the world? January 2018
New global poll finds unemployment remains the main concern around the world — but in Britain, healthcare leads as the biggest worry.
Two-thirds of Britons (65%) think the direction of the country is on the wrong track.
-
Ipsos Research Highlights - January 2018
Ipsos's Research Highlights for January 2018 includes rising concern about inflation, a lack of confidence in the Government's negotiations with the EU from FTSE 500 and how to avoid an epic fail.
-
Is there a real threat of a finance sector “Brexodus”?
Will the Banking & Finance Sector exit Britain post-Brexit, and what would be the consequences?
Ipsos’s latest research among MPs, Business Journalists and the General Public provides warning signals in terms of perceived likelihood of the financial sector moving from the UK to the EU, and highlights the serious consequences for any banks relocating abroad. -
What are the reputational and regulatory risks for businesses that automate?
Evidence from our Key Influencer and General Public surveys shows that MPs and their constituents are at odds over automation — with diverging views on the desirability of 'minimum human quotas' or an 'automation tax'.
-
Drug pricing controversies are here to stay – what do consumers think?
Drug pricing has long been a key reputational issue for the pharmaceutical industry in the eyes of consumers. In light of recent media coverage of this issue, it is unlikely that perceptions are going to shift any time soon. However, many senior stakeholder groups are positive about the future of Pharmaceuticals.